MARITECH
DEAD

Serial Number

79168653

Owner

Marinova Pty Ltd

Attorney

Jeffrey C. Joyce

Filing Date

Jul 11, 2014

Add to watchlist:

No watchlists yet
View on USPTO

MARITECH Trademark

Serial Number: 79168653 • Registration: 4948609

MARITECH is a trademark filed by Marinova Pty Ltd on July 11, 2014. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Marinova Pty Ltd (7 trademarks)

249 Kennedy Drive

Entity Type: 99

Trademark Details

Filing Date

July 11, 2014

Registration Date

May 3, 2016

Published for Opposition

February 16, 2016

Cancellation Date

July 11, 2024

Goods & Services

Extracts of seaweed or marine algae prepared for medical use; extracts of seaweed or marine algae prepared for therapeutic use; extracts of seaweed or marine algae prepared for dietary or nutritional supplement use; extracts of seaweed or marine algae having an anti-viral effect; medical therapeutic agents consisting of fucoidan; medical therapeutic biological products consisting of fucoidan; medical therapeutic biological products containing extracts of seaweed or marine algae; anti-viral agents for the treatment of viruses; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for topical use for the treatment of dermatological conditions; topical dermatological products for medical purposes; veterinary preparations for topical application for the treatment of dermatological conditions; natural preparations for skin treatment; medicated preparations for the skin; veterinary preparations for use in improving the skin; animal care products for veterinary use, namely fucoidan; medicated body care preparations, namely dermatological; medicated natural body care products for the skin; pharmaceutical preparations for health care; dietary supplements from plant extracts; plant extracts for medical use; plant extracts for pharmaceutical use; fucoidan extracts for nutritional supplement use; fucoidan extracts for medical use; fucoidan extracts for pharmaceutical use; fucoidan extracts for veterinary use; fucoidan extracts and related algal polysaccharides for medical use; compounds having an anti-inflammatory activity; anti-coagulants; anti-ulcer agents; epidermal growth factor preparations for the treatment of burns; epidermal growth factor preparations for the treatment of wounds; additives in the nature of dietary supplements for animals; medicines for veterinary purposes, namely fucoidan; plant compounds for use as dietary veterinary supplements; preparations of plants for veterinary use in the treatment of animals, namely fucoidan; lubricants containing fucoidan for medical use; lubricants for surgical purposes; personal sexual lubricants; gastrointestinal drugs; medical therapeutic drugs for the treatment of medical conditions; pharmaceutical preparations, namely acne cleansers; pharmaceutical preparations namely acne creams; anti-allergic pharmaceutical preparations; anti-sunburn preparations for pharmaceutical use; pharmaceutical anticoagulant preparations; pharmaceutical substances for use in aquaculture, namely fucoidan; nutritional animal feed supplements; nutritional feed supplements for animals; nutritional supplements for medical use; dietary nutritional supplements; medicated nutritional additives for animal foodstuffs; medicated preparations for use in the treatment of sunburn; natural preparations for skin treatment; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in the treatment of skin blemishes; pharmaceutical products for the treatment of gastrointestinal disorders; preparations for the treatment of haemophilia; preparations for the treatment of rheumatic pain; medicated skin treatment for animals; nasal decongestants; pharmaceutical preparations for nasal use; compounds for treating respiratory diseases; anti-bacterial pharmaceutical preparations; anti-bacterial preparations for veterinary use; dietary supplements for animals; dietary supplements for infants; herbal dietary supplements; nutritional supplements; plant medicinal compounds for use as dietary supplements; plant veterinary compounds for use as dietary supplements; extracts of pharmaceutical use, namely fucoidan

Fucoidan extracts for cosmetic use

Biological products for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; emulsifiers for use in the manufacture of cosmetics; polymeric chemicals for use in the manufacture of cosmetics; prepared compositions of fucoidan for use in the manufacture of cosmetics; chemical ingredients for skin care preparations; chemical ingredients for use in the manufacture of foods; chemical preparations for use as ingredients for foods; ingredients used in topical dermatological products; active chemical ingredients for skin care preparations;fucoidan for use in the manufacture of cosmetics; fucoidan ingredients for skin care preparations; fucoidan ingredients for skin care preparations and dermatological preparations; active chemicals for use in coating medical apparatus, namely fucoidan; chemical substances for use in the production of drugs; chemical products of fucoidan for use in pharmaceuticals; active chemicals for use in coating pharmaceutical products; polysaccharides for use in the manufacture of pharmaceutical products

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 31, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 31, 2025 DETH
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 2, 2022 NA71
REGISTERED-SEC.71 ACCEPTED
May 2, 2022 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2022 APRE
TEAS SECTION 71 RECEIVED
Sep 15, 2021 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 19, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 3, 2016 FICS
FINAL DISPOSITION PROCESSED
Aug 3, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 3, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
May 3, 2016 R.PR
PUBLISHED FOR OPPOSITION
Feb 16, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Feb 13, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 27, 2016 OP2R
NOTICE OF PUBLICATION
Jan 27, 2016 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 31, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2015 TROA
REFUSAL PROCESSED BY IB
Aug 15, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 27, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jul 27, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 25, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jul 24, 2015 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 15, 2015 MAFR
ASSIGNED TO EXAMINER
Jul 11, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2015 REPR